RIGEL PHARMACEUTICALS, INC. (RIGL) Net income 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$367.0MFY2025 · since FY2016: -$69.2M → $367.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $367.0M | +1999.1% |
| FY2024 | $17.5M | +169.7% |
| FY2023 | -$25.1M | +57.2% |
| FY2022 | -$58.6M | -227.0% |
| FY2021 | -$17.9M | +39.8% |
| FY2020 | -$29.7M | +55.5% |
| FY2019 | -$66.9M | +5.1% |
| FY2018 | -$70.5M | +9.6% |
| FY2017 | -$78.0M | -12.7% |
| FY2016 | -$69.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net marginRIGL Gross profitRIGL Gross marginRIGL Operating incomeRIGL Operating marginRIGL Operating cash flowRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →